These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33306781)
21. Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort study. Sinh P; Anaparthy R; Young PE; Gaddam S; Thota P; Balasubramanian G; Singh M; Higbee AD; Wani S; Gupta N; Rastogi A; Mathur SC; Bansal A; Horwhat JD; Cash BD; Falk GW; Lieberman DA; Vargo JJ; Sampliner RE; Sharma P Endoscopy; 2015 Aug; 47(8):669-74. PubMed ID: 25910065 [TBL] [Abstract][Full Text] [Related]
22. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Duits LC; Phoa KN; Curvers WL; Ten Kate FJ; Meijer GA; Seldenrijk CA; Offerhaus GJ; Visser M; Meijer SL; Krishnadath KK; Tijssen JG; Mallant-Hent RC; Bergman JJ Gut; 2015 May; 64(5):700-6. PubMed ID: 25034523 [TBL] [Abstract][Full Text] [Related]
23. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383 [TBL] [Abstract][Full Text] [Related]
24. Risk of progression in Barrett's esophagus indefinite for dysplasia: a systematic review and meta-analysis. Krishnamoorthi R; Mohan BP; Jayaraj M; Wang KK; Katzka DA; Ross A; Adler DG; Iyer PG Gastrointest Endosc; 2020 Jan; 91(1):3-10.e3. PubMed ID: 31421077 [TBL] [Abstract][Full Text] [Related]
25. Patients With Barrett's Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer. Kestens C; Offerhaus GJ; van Baal JW; Siersema PD Clin Gastroenterol Hepatol; 2016 Jul; 14(7):956-962.e1. PubMed ID: 26748222 [TBL] [Abstract][Full Text] [Related]
26. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
27. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245 [TBL] [Abstract][Full Text] [Related]
28. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ; Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200 [TBL] [Abstract][Full Text] [Related]
30. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
31. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study. Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705 [TBL] [Abstract][Full Text] [Related]
32. Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer. Falk GW; Thota PN; Richter JE; Connor JT; Wachsberger DM Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1089-94. PubMed ID: 16271339 [TBL] [Abstract][Full Text] [Related]
34. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
35. A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia. Picardo SL; O'Brien MP; Feighery R; O'Toole D; Ravi N; O'Farrell NJ; O'Sullivan JN; Reynolds JV Dis Esophagus; 2015; 28(2):121-6. PubMed ID: 24428806 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of young patients with early Barrett's neoplasia. Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218 [TBL] [Abstract][Full Text] [Related]
39. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Lim CH; Treanor D; Dixon MF; Axon AT Endoscopy; 2007 Jul; 39(7):581-7. PubMed ID: 17611911 [TBL] [Abstract][Full Text] [Related]
40. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Gopal DV; Lieberman DA; Magaret N; Fennerty MB; Sampliner RE; Garewal HS; Falk GW; Faigel DO Dig Dis Sci; 2003 Aug; 48(8):1537-41. PubMed ID: 12924649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]